The ICH Q7 Q&A Document - an Update on GMP for APIs A Pre-conference session to the 19th APIC/CEFIC European Conference

22 November 2016, Barcelona, Spain

Course No. 15437

header-image

Speakers

Anthoney Storey
Pfizer, United Kingdom

Francois Vandeweyer
Janssen Pharmaceutica, Belgium

Objectives

This pre-Conference Session provides an interpretation of the GMP principles for the manufacture of APIs against the backdrop of the ICH Q7 Questions and Answers Document.

You will get to know:
Which aspects of ICH Q7 have to be re-considered
What are the practical consequences of the ICH Q7 Q&A document
What has tobe taken into account when preparing for a GMP inspection

Furthermore you will have the opportunity to reach clarification on ambiguous issues by bringing your questions concerning ICH Q7 up for discussion.

Create your own Workshop:
You will be asked to choose 5 Questions/Answers out of the Q&A document you would like to be discussed during the workshop session.
For this purpose you will receive a questionnaire after having registered for this pre-Conference Session.

Those Questions/Answers of the Q&A Document chosen by the participants as being of main interest will be discussed during the afternoon workshop session.

This pre-conference session ideally complements the following 19th APIC/CEFIC European Conference on Active Pharmaceutical Ingredients.

Background

Since its successful implementation in the regulatory framework by most authorities around the world experience has been gained with the ICH Q7 Guideline on „Good Manufacturing Practice for Active Pharmaceutical Ingredients“. Meanwhile it turned out that ambiguities related to the interpretation of some sections in ICH Q7 may lead to misconceptions. Furthermore the principles outlined in the ICH Guidelines Q8 – Q11, in particular the life cycle approach and some technical issues related to API manufacturing procedures, need also to be considered in order to achieve a comprehensive implementation of GMP for APIs.

The ICH Q7 Questions & Answers Document which reached Step 4 of the ICH process in June 2015 intends to remove these ambiguities and to contribute as well to harmonization of GMP inspections of both small molecules and biotech APIs.

Target Group

This pre-conference session is designed for all persons involved in the manufacture of APIs especially for persons from production, quality control, quality assurance and control, technical and regulatory affairs departments. We are also addressing interested parties from the pharmaceutical industry and GMP inspectorates.

Programme

The ICH Q7 Questions and Answers Document – an overview
Intention of the Q&A Document
Content
Some highlights from the Q&A Document
Advantages to Industry of the Q&A document

Interpretation of the ICH Q7 Guide: APIC’s „How to do Document“
Information on APIC
Purpose of the “How to do” Document
Content and highlights
Interrelationship to the ICH Q7 Q&A document

Worked examples from the ICH Q7 Q & A Document

Workshop

Important Questions/Answers out of the ICH Q7 Q&A Document
The Q&As of main interest chosen by the participants of the pre-Conference Session will be discussed –

This training/webinar cannot be booked. Send us your inquiry by using the following contact form.

To find alternative dates for this training/webinar or similar events please see the complete list of all events.

For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.

* also payable by credit card
American Express Visa Mastercard

icon
Additional dates on-site
Additional dates on-site
not available
icon
Additional dates online
Additional dates online
not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025